Lyell Immunopharma

Lyell Immunopharma is a clinical-stage biotechnology company focused on developing transformative cell therapies for patients battling solid tumors. They are pioneering novel T-cell reprogramming technologies designed to overcome major barriers to effective cell therapy in solid tumors, specifically T-cell exhaustion and lack of durable stemness. Their approach centers on reprogramming T cells to resist exhaustion, retain function, and enhance durable stemness, ultimately leading to more potent and long-lasting anti-tumor activity.

Lyell has built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Their diverse pipeline targets various solid tumor cancers with high unmet needs, including triple-negative breast cancer, non-small cell lung cancer, ovarian cancer, endometrial cancer, melanoma, and colorectal cancer. The company boasts a team of experienced leaders and scientific advisors who are pioneers in the field of oncology and cell therapy, driving Lyell's commitment to scientific innovation and their ultimate goal of achieving curative cell therapy for solid tumors.

Lyell Immunopharma offers a flexible work environment that combines the ability to work onsite as roles require with the flexibility to work remotely. The company's onsite facilities are designed to inspire employees' best work with open work and collaboration spaces, state-of-the-art labs, and best-in-class technologies. Located in South San Francisco, Seattle, and Bothell, these locations offer modern amenities, cafeterias, mothers' rooms, and free parking. The company also provides weekly lunches for employees to come together and build a sense of community, and some locations offer onsite gyms, showers, and fitness classes.

Lyell offers a comprehensive benefits package to its employees, including subsidized medical, dental, and vision plans, a 401(k) plan with a company match, an Employee Stock Purchase Plan, a generous paid time-off policy, commuter benefits, and a range of supplemental benefits to choose from. They also provide weekly lunches for employees to foster a sense of community and offer onsite gyms, showers, and fitness classes at some locations.

Lyell Immunopharma is a clinical-stage company dedicated to developing transformative cell therapies for patients with solid tumors. They are pioneering novel T-cell reprogramming technologies designed to overcome major barriers to effective cell therapy for solid tumors, such as T-cell exhaustion and lack of durable stemness. Their mission is to advance a diverse pipeline of cell therapies that can go the distance for patients with solid tumors and ultimately defeat solid tumor cancers through innovation.

Lyell promotes a culture based on science, respect, collaboration, and courage. The company values evidence over opinion, challenges the status quo, assumes positive intent, and works together across teams to solve problems. They believe in creating an environment where everyone can do their best work, be themselves, and thrive personally and professionally. This culture is reflected in their commitment to building an open, diverse, and inclusive workplace where employees feel valued and empowered to contribute to the mission of developing cures for cancer patients.

Lyell Immunopharma believes that diversity, equity, and inclusion are crucial to its success. They strive to build an open, diverse, and inclusive culture for all employees, recognizing that different backgrounds and experiences lead to better outcomes. Their commitment to building a diverse team is highlighted in their hiring practices, where they actively seek out exceptional talent from a wide range of backgrounds. This approach fosters a culture where employees feel comfortable being themselves and can thrive personally and professionally.